Contrast-enhanced MR imaging may serve as the key to diagnosing myocarditis, an inflammatory heart condition that leads to chronic dilated cardiomyopathy in as many as one of every 10 patients and sudden death in some cases. A study presented at the SCMR meeting provided a strong argument for adopting the strategy to find and monitor the condition.
Contrast-enhanced MR imaging may serve as the key to diagnosing myocarditis, an inflammatory heart condition that leads to chronic dilated cardiomyopathy in as many as one of every 10 patients and sudden death in some cases. A study presented at the SCMR meeting provided a strong argument for adopting the strategy to find and monitor the condition.
"Contrast enhancement is a frequent finding in the clinical setting of myocarditis," said Dr. Heiko Mahrholdt, a cardiologist at Robert Bosch Medical Center in Stuttgart, Germany.
Mahrholdt described his group's experience with 32 patients who presented with symptoms suggesting myocarditis: flulike conditions experienced within two months of hospital admission, chest pain, shortness of breath, tachycardia, and an ECG pattern consistent with the presence of the disease. The study group comprised 26 men and six women. Results were published in the March issue of Circulation.
The ECG-gated, inversion-recovery cardiac MR protocol was performed five to 10 minutes after an infusion of 0.1 mmol/kg of gadolinium. Image acquisition covered the myocardium from apex to base in 6-mm slices. Procedures were completed in 20 to 30 minutes, and two blinded readers interpreted the results.
Contrast enhancement appeared in 28 of the 32 cases, Mahrholdt said. Readers observed patchy enhancement that most often appeared subepicardially in the lateral free wall. Of the 21 cases in which histological material had been harvested from the enhanced regions, 19 confirmed the diagnosis of myocarditis. The enhanced regions were rich in macrophages and lymphocytes indicative of myocardial damage. Contrast-enhanced areas decreased from an average 9% to 3% of left ventricular mass when MR imaging was repeated 12 weeks later. Mahrholdt associated this change with the shrinkage of scar that replaced the necrotic tissue during healing.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.